| | |
 |  | |
 | ||
 | | 
16-Jan-12
Notification of Major Interest in Shares 05-Jan-12 Result of General Meeting 04-Jan-12 Total Voting Rights   General Meeting Voting Results (PDF) 2011 AGM Presentation (PDF) 2010 Annual Report (PDF) 2011 AGM Notice (PDF)
Notice of 5 January 2012
  Subscribe to our Email List | |  Verona Pharma plc is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic rhinitis (hay fever), chronic obstructive pulmonary disease (COPD) and cough. Verona Pharma currently has three potential drug treatments under development and continues to look for other possible drug development opportunities aimed at the respiratory and inflammatory diseases markets. Verona Pharma is incorporated in the United Kingdom and has its principal office in central London. Verona Pharma is traded on the AIM stock exchange under the symbol VRP. The information on this website is made available pursuant to AIM Rule 26. This website was last updated on 5 January 2012. | | |
| ||
| | |
| ||
| Home Company Information Products AIM Rule 26 News Releases Contact For Staff | |
| ©2006 Verona Pharma Plc All Rights Reserved. | Disclaimer | |